Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 09 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-09-2024-4

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 09, 2024, titled "Zydus receives Tentative Approval from the USFDA for Dexamethasone Tablets USP, 1 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

In the deck

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases